You’ve heard of the $64,000 question.
Now there’s a $64,000 — make that $64,500 — answer called ThisIsLucre.com, a niche product offering targeting wealth management firms seeking “radical revenue growth” through its snazzy websites.
While boutique strategic communication firm BigMouth has worked for 20 years on blue chip accounts including Apple, Dell and Oracle, founding partner Mike Yoffie told ThinkAdvisor that smaller companies have often sought estimates they felt they could not afford.
“When people would say ‘That’s great but we can’t afford it,’ I’d say “So wait until you can afford it because other solutions [just won’t cut it]. Ours is going to pay for itself many times over.”
Yoffie, who says about 40% of his San Francisco-based firm’s clients are in the financial services industry, says wealth management firms particularly were attracted to the kind of work they did for Private Ocean.
10 Best Safest Stocks To Invest In 2015: Madison Square Garden Inc.(MSG)
The Madison Square Garden Company, together with its subsidiaries, operates in the sports, entertainment, and media businesses primarily in the United States. The company operates in three segments: MSG Media, MSG Entertainment, and MSG Sports. The MSG Media segment produces and develops content for various distribution platforms, including content originating from the company?s venues. It consists of the MSG Networks and the Fuse Networks, which offer sports and musical content. This segment also manages interactive businesses that comprise a range of targeted websites; and wireless, video on demand, and digital platforms. The MSG Entertainment segment creates, produces, and/or presents various live productions, as well as presents or hosts other live entertainment events, such as concerts, family shows, special events, and theatrical productions. The MSG Sports segment owns and operates sports franchises. This segment also owns other sports properties, including the pre sentation of a range of live sporting events, such as professional boxing, college basketball, track and field, and tennis. The company owns the Madison Square Garden complex in New York City, which includes an arena and a theater; and The Chicago Theatre in Chicago. It leases Radio City Music Hall and the Beacon Theatre in New York City. The company is based in New York, New York. As of February 09, 2010, Madison Square Garden, Inc. operates independently of Cablevision Systems Corporation.
- [By Ben Levisohn]
Companies that could be hurt by tax reform due to their already low tax rates include Broadcom (BRCM) and Celgene (CELG), while Best Buy (BBY), Madison Square Garden (MSG) and Gap (GPS) could benefit, Senyek says.
- [By Jayson Derrick]
Madison Square Garden (NASDAQ: MSG) is considering splitting itself in to two companies; the first division will focus on sports and media, while the other will focus on real estate holdings. Shares hit new 52-week highs of $74.00 before closing the day at $73.00, up 10.98 percent.
10 Best Safest Stocks To Invest In 2015: Medina International Holdings Inc (MIHI)
Medina International Holdings, Inc. (Medina), incorporated on June 23, 1998, manufactures products and services to assist emergency and defense organizations and personnel. The Company, through its two wholly owned subsidiaries, Harbor Guard Boats, Inc. (HGB) and Medina Marine, Inc. manufactures and sells recreational and commercial boats. The products are manufactured by HGB, which designs, manufactures, and markets hand-laid fiberglass and aluminum commercial boats ranging from 15 feet to 37 feet, which are utilized by fire, search and rescue, emergency, patrol, military and defense organizations. It manufactures commercial and recreational watercrafts.
As of April 30, 2012, HGB had nine models of commercial and recreational watercrafts. The Company’s products consist of commercial boats and recreational boats. As of April 30, 2012, Medina had seven commercial watercraft models, ranging from 15 feet to 37 feet in length. Its other watercraft includes 15 f eet interceptor, which is used for rescue and fiber glass; 20-feet interceptor, which is used for fire rescue, rescue and fiber glass; 21 feet firecat, which is used for fire rescue, rescue and fiber glass; 24 feet firecat/denfender, which is used for fire rescue, rescue, aluminum and fiber glass; 26 feet firecat/denfender, which is used for fire rescue, rescue, aluminum and fiber glass; 30 feet firecat/denfender, which is used for fire rescue, rescue, aluminum and fiber glass, and 37 feet firecat/denfender, which is used for fire rescue, rescue, aluminum and fiber glass. As of April 30, 2012, the Company had two recreational watercraft models. Its watercraft products are made out of fiberglass and aluminum materials.
- [By Peter Graham]
Last Friday, small cap Digital Brand Media & Marketing Group Inc (OTCMKTS: DBMM) surged 22.22% while Blue Water Global Group Inc (OTCBB: BLUU) sank 18.42% and Medina International Holdings, Inc (OTCMKTS: MIHI) sank 50%. However, one of these small caps (Blue Water Global Group) appears to be reversing course in early morning trading today. So with it and the rest of these small cap stocks either sink or swim in trading this week? Here is a closer look to help you decide on an investing or trading strategy:
10 Best Safest Stocks To Invest In 2015: Japan Petroleum Exploration Co Ltd (JPTXF)
Japan Petroleum Exploration Co., Ltd. is a company principally involved in the energy business. The Company operates in four geological segments. The Japan segment involves in the production, purchase and sale of crude oil and natural gas in Japan, the contracting of drilling and refurbishment works, mud logging works, research works, geophysical exploration works, the provision of pipeline maintenance services and security guard services, the purchase and sale of petroleum products, the transportation of petroleum and natural gas products, as well as real estate management business. The North America segment involves in the exploration and development of crude oil and natural gas in North America. The Middle East segment involves in the development of crude oil and natural gas. The Others segment involves in the exploration, development and production of crude oil and natural gas in Southeast Asia. As of March 31, 2013, the Company had 26 subsidiaries and 17 associated compa nies. Advisors’ Opinion:
- [By WWW.MARKETWATCH.COM]
LOS ANGELES (MarketWatch) — Japanese stocks have ended with losses in every session this week, and sure enough, the Nikkei Average (JP:NIK) was down 0.6% in early Friday trade, though off an opening 0.8% defecit, while the Topix carried a 0.7% loss. Overnight losses for the U.S. and further strength in the yen (with the dollar falling to ¥101.28 from ¥101.56 a day earlier) helped drag the market lower, as did results from Fast Retailing Co. (JP:9983) (FRCOF) , the shares of which hold the heaviest weighting on Nikkei Average. Fast Retailing said that while its Uniqlo brand was doing great business, weakness for its J Brand luxury demin label helped send September-May profit down 4% and prompted another cut to Fast’s full-year outlook. Consequently, its shares traded 0.7% lower, though rivals Takashimaya Co. (JP:8233) and J. Front Retailing Co. (JP:3086) (JFROF) also saw losses of 0.6% and 0.5%, respectively. Among other decliners, Sony Corp. (JP:6758) (SNE) lost 0.7%, Toshiba Corp. (JP:6502) (TOSYY) fell 2.1%, Kawasaki Heavy Industries Ltd. (JP:7012) (KWHIY) fell 1.5%, Toyota Motor Corp. (JP:7203) (TM) and Nissan Motor Co. (JP:7201)
10 Best Safest Stocks To Invest In 2015: BP p.l.c.(BP)
BP p.l.c. provides fuel for transportation, energy for heat and light, retail services, and petrochemicals products. Its Exploration and Production segment engages in the oil and natural gas exploration, field development, and production; midstream transportation, and storage and processing; and marketing and trading of natural gas, including liquefied natural gas (LNG), and power and natural gas liquids (NGL). This segment has exploration and production activities in Angola, Azerbaijan, Canada, Egypt, Norway, Russia, Trinidad and Tobago, the United Kingdom, and the United States, as well as in Asia, Australasia, South America, North Africa, and the Middle East. This segment also owns and manages crude oil and natural gas pipelines; processing facilities and export terminals; and LNG processing and transportation, as well as NGL extraction facilities. BP p.l.c. has interests in the Trans-Alaska pipeline system, the Forties pipeline system, the Central Area transmission sys tem pipeline, the South Caucasus Pipeline, and Baku-Tbilisi-Ceyhan pipeline, as well as in LNG plants located in Trinidad, Indonesia, and Australia. The company?s Refining and Marketing segment involves in the supply and trading, refining, manufacturing, marketing, and transportation of crude oil, petroleum, and petrochemicals products and related services to wholesale and retail customers primarily under the BP, Castrol, ARCO, and Aral brands. Its Other Businesses and Corporate segment produces and markets rolled aluminum products, as well as generates energy through wind, solar, biofuels, hydrogen, and carbon capture and storage sources; and engages in shipping activities. The company was founded in 1889 and is headquartered in London, the United Kingdom.
- [By WWW.DAILYFINANCE.COM]
We’re in the same shoes as the consumer, the cost of fuel is less for us.
“We’re in the same shoes as the consumer, the cost of fuel is less for us,” says Kevin Beyer, who owns Performance Fuels, a filling station and convenience store in Smithtown, New York. That means profits for Beyer and the nation’s 127,000 filling stations are rising. Before they sell gas to you, station owners buy gas on the wholesale market. When the wholesale price of gasoline falls quickly the difference between the cost of wholesale gasoline (including taxes) and the price at the pump gets wider, boosting profits for stations. The steeper the drop, the better. “It’s completely antithetical to what people believe,” says Tom Kloza, chief oil analyst at the Oil Price Information Service. That difference has stretched to 21.7 cents a gallon this year, the highest ever, according to an OPIS analysis of 16,000 U.S. stations. That compares to an average of 17.1 cents over the last five years. On a percentage basis, station profitability is at its highest since 2005. And profits on diesel sales are even higher. “They are off the charts,” Kloza says. Yes, that means you could be paying even less for gasoline than you are. But before you cry foul, you should know that after all the ups and downs in a year, gas stations do not make much money from selling gasoline. After credit card fees and other operating costs, net profit for gasoline sales averages 3 cents a gallon, according the National Association of Convenience Stores. Scraping By When gas prices soar, and drivers think they’re being gouged, stations are barely scraping by or even losing money. When the wholesale price is soaring, like it did in 2008, 2011 and 2012, station owners can’t increase the price at the pump as fast as their costs are going up or they risk losing customers to competitors. When the wholesale price is going down, like now, there isn’t the same pressure to lower the price. Drivers are so happy to se
- [By Ben Levisohn]
HSBC’s Gordon Gray and team think it’s time to start buying big oil companies like Total (TOT), Chevron (CVX) and BP (BP). In a report released yesterday, they explained why:
10 Best Safest Stocks To Invest In 2015: Acacia Research Corporation(ACTG)
Acacia Research Corporation, through its subsidiaries, acquires, develops, licenses, and enforces patented technologies in the United States. It assists patent owners with the prosecution and development of their patent portfolios; protection of their patented inventions from unauthorized use; generation of licensing revenue from users of their patented technologies; and enforcement against unauthorized users of their patented technologies. The company owns or controls the rights to approximately 200 patent portfolios, which include the United State?s patents and foreign counterparts covering technologies used in various industries. Acacia Research Corporation was founded in 1992 and is based in Newport Beach, California.
- [By Luke Jacobi]
Acacia Research (NASDAQ: ACTG) shares shot up 16.8 percent to $17.49 after the company reported upbeat Q2 results and approved a $0.125 per share quarterly dividend.
- [By Garrett Cook]
Acacia Research (NASDAQ: ACTG) shares shot up 15.69 percent to $17.33 after the company reported upbeat Q2 results and approved a $0.125 per share quarterly dividend.
- [By Garrett Cook]
Acacia Research (NASDAQ: ACTG) shares shot up 14.82 percent to $17.20 after the company reported upbeat Q2 results and approved a $0.125 per share quarterly dividend.
- [By Jake L’Ecuyer]
Acacia Research (NASDAQ: ACTG) shares tumbled 6.98 percent to $15.87 after the company reported weaker-than-expected Q1 results.
athenahealth (NASDAQ: ATHN) was down, falling 5.80 percent to $137.14 after the company reported downbeat quarterly results. Morgan Stanley analyst Ricky R. Goldwasser removed the $133.00 price target on athenahealth.
10 Best Safest Stocks To Invest In 2015: Alkaline Water Company Inc (WTER)
The Alkaline Water Company Inc., formerly Global Lines Inc, incorporated on June 6, 2011, is a developer of electrolysis beverage process, packaged and branded as Alkaline84. Alkaline84 is the Company’s flagship product designed to encourage daily consumption of Alkaline Water through a consumer oriented bulk delivery system. The Company is engaged in the development of a national retail bulk distribution network delivering Electrochemically Activated Water (ECA) to consumers everywhere. The Company is focused on the business of distributing and marketing the retail sale of its packaged Alkaline84 branded beverage products.
Alkaline84 is available in two sizes: three liters and one gallon. Alkaline84 is a pH balanced bottled alkaline drinking water enhanced with 84 trace minerals and electrolytes. Alkaline84 is available for consumer sales at a number of major retail locations across the southwestern United States.
- [By James E. Brumley]
The initial thought may be that it’s a bit of an awkward sales venue. The more one thinks about it – and digs – the more this relationship makes sense. And if you did really deep into the details (into a philosophical level), a “whole is greater than the sum of its parts” scenario surfaces. What’s this not-really-unusual relationship? The Alkaline Water Company Inc. (OTCBB:WTER) is now selling its Alkaline88 brand of water through Amazon.com, Inc. (NASDAQ:AMZN). Take that Primo Water Corporation (NASDAQ:PRMW)!
- [By Bryan Murphy]
If you’ve lost count of how many distributors Alkaline Water Company Inc. (OTCBB:WTER) has working for it now, you’re not alone. Ditto for the number of grocers that are offering its flagship produce… one-gallon bottles of Alkaline84 water (some of the best-tasting and healthiest spring water you could ever drink). So many distributors and grocery store chains have just started carrying Alkaline84 within the past two months that it’s been nearly impossible to keep up with how quickly WTER has gotten its ball rolling. There is one thing that’s clear though – Alkaline Water Company has a LOT of momentum right now, up from none at the beginning of July. Take a look at all the doors the company has opened since it actually began marketing its bottled water:
- [By John Udovich]
Small cap OTC drinking water stocks Glacier Water Services, Inc (OTCMKTS: GWSV), AWG International Water Corp (OTCBB: AWGI) and Alkaline Water Company Inc (OTCBB: WTER) all offer a product that many consumer, investors and traders alike might take for granted, but everyone needs to have. However, you can build a better mouse trap when it comes to drinking water or at least that what these three small caps are attempting to do with their own unique strategies:
10 Best Safest Stocks To Invest In 2015: Sarepta Therapeutics Inc (SRPT)
Sarepta Therapeutics Inc., formerly AVI BioPharma, Inc., incorporated on July 22, 1980, biopharmaceutical company focused on the discovery and development of ribonucleic acid (RNA)-based therapeutics for the treatment of rare and infectious diseases. The Company’s product candidates include Eteplirsen, AVI-6002, AVI-6003, and AVI-7100. As of December 31, 2011, the Company primarily focused on advancing the development of its Duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen, which is in a Phase IIb trial. The Company is also focused on developing therapeutics for the treatment of infectious diseases, including its lead infectious disease programs aimed at the development of drug candidates for the Ebola and Marburg hemorrhagic fever viruses. The Company’s program focuses on the development of disease-modifying therapeutic candidates for Duchenne muscular dystrophy (DMD). The Company initiated a Phase IIb trial for eteplirsen in August 2011 with an objective of initiating a pivotal trial subsequent to 2011.
The Company is also leveraging the capabilities of its RNA-based technology platforms to develop therapeutics for the treatment of infectious diseases. The Company’s RNA-based drug programs are clinically evaluated for the treatment of DMD and have also demonstrated anti-viral activity in infectious diseases such as Ebola, Marburg and H1N1 influenza in certain animal models. The Company’s lead product candidates are at various stages of development.
Duchenne Muscular Dystrophy Program
The Company’s lead program is designed to address specific gene mutations that result in DMD by forcing the genetic machinery to skip over an adjacent contiguous piece of RNA and, thus, restore the ability of the cell to express a new, truncated but functional, dystrophin protein.
Eteplirsen is an antisense PMO-based therapeutic in clinical development for the treatmen t of individuals with DMD who have an error in the gene codi! ng for dystrophin that can be treated by skipping exon 51. Eteplirsen targets the frequent series of mutations that cause DMD. Eteplirsen has been granted orphan drug designation in the United States and European Union. In addition to the Company’s lead product candidate, eteplirsen, the Company is actively pursues development of a product candidate that skips exon 45 through an IND-enabling collaboration.
The Company is implementing its RNA-based technology platforms in its anti-viral programs for the development of therapeutics to treat viruses, such as Ebola, Marburg and influenza. The Company’s arrangement with DoD supporting the development of the Company’s Ebola and Marburg virus drug candidates provides funding for all clinical and licensure activities necessary to obtain approval of a New Drug Application (NDA), by the United States Food and Drug Administration (FDA), if DoD exercises all of its options under the arrange ment. During the year ended December 31, 2011, the Company paused its clinical development efforts on AVI-7100 and is exploring funding opportunities or partnerships with DHHS and industry collaborators to advance its development.
The Company’s anti-viral therapeutic programs use the Company’s translation suppression technology and applies its PMOplus chemistry backbone, an advanced generation of its base PMO chemistry backbone that selectively introduces positive backbone charges to improve selective interaction between the drug and its target. The Company’s translation suppressing technology is based on Translation Suppressing Oligomers (TSOs), which are PMO-based compounds that stop or suppress the translation of a specific protein by binding to their specific target sequence in mRNA.
The Company is pursuing development and regulatory approval of its Ebola and Marburg hemorrhagic fever virus product candidates under the FDA’s Animal Rule. The Co mpany’s lead product candidate against the Ebola virus infec! tion is A! VI-6002. For Marburg virus infection, the Company’s lead product candidate has been AVI-6003. In February 2012, the Company announced that the Company received approval from the FDA to remove one of the two oligomers composing AVI-6003 and proceed with a single oligomer approach, AVI-7288, given that efficacy in non-human primates has been demonstrated to be attributable to this single oligomer. The Company is exploring the feasibility of alternate routes of administration of its Ebola and Marburg drug candidates, and at DoD’s invitation, the Company is developing a proposal to be submitted for a study to demonstrates feasibility of the intramuscular route.
AVI-6002, which is a combination of AVI-7537 and AVI-7539, is designed for post-exposure prophylaxis after documented or suspected exposure to the Ebola virus. The Company is evaluating the feasibility of developing AVI-7537 as a single agent for the post-exposure prophylaxis after documented or suspected exp osure to Ebola virus. AVI-6003, which is a combination of AVI-7287 and AVI-7288, is designed for post-exposure prophylaxis after documented or suspected exposure to Marburg virus. In February 2012, the Company announced that the Company received approval from the FDA to proceed with AVI-7288 as a single agent against Marburg virus infection. The Company intends to proceed with dosing AVI-7288 in the Phase I multiple ascending dose studies and in non-human primate studies.
The Company’s anti-viral therapeutic programs are also focused on the development of the Company’s product candidates designed to treat pandemic influenza viruses. AVI-7100 is the Company’s lead product candidate for the treatment of influenza and employs its PMOplus technology. In June 2011, the Company initiated dosing of AVI-7100 through intravenous infusion in single-ascending doses in up to 48 healthy adult volunteers. As of December 31, 2011, the Company pau sed its clinical development efforts on AVI-7100 and are exp! loring fu! nding opportunities or partnerships to advance its development.
The Company has developed three new phosphorodiamidate-linked morpholino oligomers (PMO)-based chemistry platforms in addition to its original PMO-based technology. The Company’s PMO-based molecules are designed to sterically block the access of cellular machinery to pre-mRNA and mRNA without degrading the RNA. Through this selective targeting, two distinct biologic mechanisms of action can be initiated: modulation of pre-mRNA splicing and inhibition of mRNA translation.
The Company competes with GlaxoSmithKline plc, Toyama Chemical, Alnylam Pharmaceuticals, Inc., Tekmira Pharmaceuticals Corp., Isis Pharmaceuticals, Inc., Prosensa, and Santaris Pharma A/S.
- [By Jayson Derrick]
The FDA issued a statement related to Sarepta Therpaeutics (NASDAQ: SRPT) eteplirsen drug, noting that that the methods used in the study were not “adequately robust to support an NDA submission” and that it provided the company with recommendations on how to improve its analysis.” Shares gained 2.80 percent, closing at $16.17.
- [By Jayson Derrick]
Analysts at Baird downgraded Sarepta Therapeutics (NASDAQ: SRPT) to Neutral form Outperform with a price target lowered to $21 from a previous $53. Shares lost 4.97 percent, closing at $15.12.
- [By Ben Levisohn]
Biotech companies that are most likely to benefit because they are “Ahead in clinical development and/or have established relationships with [the Biomedical Advanced Research and Development Authority, or] BARDA which may facilitate getting a contract” include GlaxoSmithKline (GSK), NewLink Genetics (NLNK), Johnson & Johnson (JNJ) and Chimerix (CMRX). Kantor includes Tekmira (TKMR) and Sarepta (SRPT) among “companies with viable programs” that are “moving forward and likely to attract additional funding.”
- [By Jayson Derrick]
Sarepta Therapeutics (NASDAQ: SRPT) said that the FDA would require additional data concerning the company's eteplirsen NDA including an independent assessment of dystrophin images as well as additional details over a minimum duration of safety in new patients exposed to eteplirsen. The company remains confident it will submit the NDA by the middle of next year. Shares plunged 32.47 percent, closing at $15.91.
10 Best Safest Stocks To Invest In 2015: Proto Labs Inc (PRLB)
Proto Labs, Inc. (Proto Labs), incorporated in 1999, is an online and technology-enabled quick-turn manufacturer of custom parts for prototyping and short-run production. Proto Labs provides Real Parts, Really Fast to product developers worldwide. The Company utilizes computer numerical control (CNC), machining and injection molding to manufacture custom parts for its customers. The Company focuses its services to the millions of product developers who use three-dimensional computer-aided design (3D CAD), software to design products across a diverse range of end-markets. The Company has established its operations in the United States, Europe and Japan, three of the geographic markets where these product developers are located. Its manufacturing services include CNC machining and plastic injection molding. In August 2013, Proto Labs, Inc. purchased the Plymouth Industrial Building at 2600 Niagara Lane, Plymouth, MN.
Proto Labs has developed software and advanc ed manufacturing processes that automate much of the skilled labor conventionally required in quoting, production engineering and manufacturing custom parts. The Company’s Firstcut and Protomold services offer many product developers the ability to outsource their low-volume, quick-turn custom parts manufacturing. Its Firstcut service uses commercially-available CNC machines to cut blocks of material into one or more custom parts based on the 3D CAD model uploaded by the product developer. The Firstcut service is well suited to produce small quantities, typically in the range of one to ten parts. Its Protomold service uses its 3D CAD-to-CNC machining technology for the automated design and manufacture of aluminum injection molds, which are then used to produce custom injection-molded plastic parts on commercially-available equipment. Its Protomold service is used for both prototype and short-run production.
- [By Steve Heller]
As Costco’s Jim Sinegal once put it, “Culture is not the most important thing — it’s the only thing” — likely because he understands the advantages of creating a work environment with high employee satisfaction. I recently had the opportunity to engage over email with Renee Conklin, Proto Labs’ (NYSE: PRLB ) vice president of human resources, about the company’s culture, employee morale, how it cultivates talent, and more. Below is a transcript of our conversation, lightly edited for style.
- [By Garrett Cook]
Proto Labs (NYSE: PRLB) shares tumbled 17.11 percent to $57.50 on weaker-than-expected Q3 results.
Yelp (NYSE: YELP) was down, falling 14.99 percent to $59.70 after the company reported upbeat results for the third quarter, but issued a weak Q4 outlook.
10 Best Safest Stocks To Invest In 2015: Caseys General Stores Inc.(CASY)
Casey?s General Stores, Inc., together with its subsidiaries, operates convenience stores under the Casey?s General Store, HandiMart, and Just Diesel names in 11 Midwestern states, primarily Iowa, Missouri, and Illinois. Its stores offer foods, beverages, dairy and bakery products, sandwiches, fountain drinks, donuts, cookies, brownies, Danish rolls, ham and cheese sandwiches, pork and chicken fritters, sausage sandwiches, chicken tenders, popcorn chicken, breakfast croissants and biscuits, breakfast pizza, hash browns, quarter-pound hamburgers and cheeseburgers, and potato cheese bites. The company?s stores also provide nonfood items, which include tobacco products, health and beauty aids, school supplies, house wares, pet supplies, photo supplies, and automotive products. In addition, it offers gasoline or gasohol for sale on a self-service basis. As of July 31, 2011, the company operated 1,665 stores. The company was founded in 1959 and is headquartered in Ankeny, Iowa.
- [By Sue Chang]
Casey’s General Stores (CASY) is likely to post fiscal fourth-quarter earnings of 53 cents a share. Strong merchandise sales were likely to have been offset by weaker fuel margin, according to analyst Ronald Bookbinder at Benchmark. He also maintained the stock’s price target at $86 on Friday.
- [By WWW.DAILYFINANCE.COM]
Slow but steady — that seems to be the new mantra here on Wall Street. The Dow Industrials and the S&P 500 plowed further into record territory on Friday. The catalyst for today’s advance was the monthly jobs report, which showed the total number of people employed finally topped the 2008 peak it hit just before the Great Recession took hold. The Dow Jones industrial average (^DJI) gained 88 points, the Standard & Poor’s 500 index (^GPSC) rose 9, and the Nasdaq composite (^IXIC) gained 25 points. Financial stocks helped lead the advance. Goldman Sachs (GS) and American Express (AXP) both gained more than 2 percent. Bank of America (BAC) rose 1 percent on reports that it’s in talks with the Justice Department to settle another set of probes into the bank’s handling of mortgages leading up to and during the financial crisis. News reports say the company could pay more than $12 billion, which is more than it earned in all of 2013. But this could allow Bank of America to finally put this long-running problem behind it. Its stock has been virtually flat over the past 6 months. Amazon (AMZN) posted a strong gain for second straight day, rising 2 percent, on indications that it’s about to enter the smartphone business. And Sears (SHLD) gained nearly 2 percent on a Reuters report that the company’s chairman has held talks with outgoing Ford (F) CEO Alan Mulally, sparking rumors that he might head the retailer’s turnaround effort. Elsewhere, Hertz (HRZ) drove into a ditch, sliding 9 percent after saying it will restate earnings from 2011 through 2013 because of accounting issues. Diamond Foods (DMND) fell 11 percent. Its quarterly loss widened, due to higher wholesale prices for nuts. But Vail Resorts (MTN), Men’s Wearhouse (MW), and VeriFone (PAY) all gained after beating expectations. Vail was up 6 percent; Men’s Wearhouse rose 5½ percent; and VeriFone jumped 9 percent. Demand for its merchant payment systems has been helped by growing con
- [By John Kell and Lauren Pollock var popups = dojo.query(“.socialByline .popC”); ]
Casey’s General Stores Inc.(CASY) said its fiscal third-quarter earnings fell 5.1% as the convenience-store operator reported higher costs, which offset an increase in revenue.
- [By Mike Deane]
After the closing bell on Monday, Casey’s General Stores (CASY) reported its third quarter earnings, posting slightly lower EPS than last year’s Q3 figure, due in part to extreme winter weather.
CASY’s Earnings in Brief
CASY reported third quarter revenues of $1.79 billion, up from last year’s Q3 figure of $1.66 billion. Net income for the quarter came in at $14.67 million, or 38 cents per share, which is lower than last year’s Q4 figure of $15.46 million, or 40 cents per share. Casey’s missed analysts’ estimates of 49 cents EPS on revenues of $1.84 billion.
CASY”s chairman and CEO, Robert J. Myers, had the following comments: “Third quarter sales were strong throughout all of our categories despite challenging weather during the quarter. Our same-store fuel sales are exceeding industry-wide trends and gross profit from inside the store was up over 11% for both the quarter and year.”
Casey’s declared a dividend raise in June last year, pushing its quarterly payout to 18 cents from 17 cents. The company’s next dividend is payable on May 15 to all shareholders on record as of May 1.
Casey’s stock ended the day up $1.52, or 2.29%, but it was heading lower in after hours earnings, due to the company’s large earnings miss. YTD, the company’s stock is down 3.7%.
10 Best Safest Stocks To Invest In 2015: Health Net Inc. (HNT)
Health Net, Inc., through its subsidiaries, provides managed health care services. The company offers commercial health care products, such as health maintenance organization plans through contracts with participating network physicians, hospitals, and other providers; preferred provider organization plans that provide coverage for services received from health care provider; and point of service plans. It also provides Medicare products, including Medicare advantage plans with and without prescription drug coverage; and Medicare supplement products that supplement fee-for-service Medicare coverage. In addition, the company offers Medicaid and related products; indemnity insurance products; auxiliary non-health products, such as life, accidental death and dismemberment, dental, vision, and behavioral health insurance; and other specialty services and products comprising pharmacy benefits, behavioral health, dental, and vision products and services, as well as managed care products for hospitals, health plans, and other entities. Further, it engages in government-sponsored managed care federal contract with the Department of Defense under the TRICARE program in the North Region; and other health care, mental health, and behavioral health government contracts. The company provides administrative services comprising provider network and referral management, medical and disease management, enrollment, customer service, clinical support service, and claims processing service to military health system eligible beneficiaries. It serves approximately 5.4 million individuals in the United States through group, individual, Medicare, Medicaid, the U.S. Department of Defense, and Veterans Affairs programs. Health Net, Inc. was founded in 1979 and is headquartered in Woodland Hills, California.
- [By iStockAnalyst]
Overall: Health Net, Inc. (NYSE:HNT) could have some significant upside if Bank of America has made the correct call, and a whole lot more than Fischbeck’s targets if the P/E stays in close proximity to the half-decade average.
- [By Ben Levisohn]
United’s disappointment has helped drag down other health insurers. WellPoint (WLP) dropped 1.3% to $88.53, Health Net (HNT) has fallen 1.7% to $31.25, Aetna (AET) has declined 2.4% to $64.11 and Cigna (CI) is off 3.5% at $77.69.
- [By Sean Williams]
What: Shares of Health Net (NYSE: HNT ) , a managed health-care provider, jumped higher by as much as 18% following the release of the company’s first-quarter earnings results. Shares have since given back a majority of their gains and are up “just” 7% as of this writing.